Osteosarcoma Causes: Genetic and Lifestyle Risk Factors

Bone cancers happening in teenagers are especially difficult to diagnose, and they trouble both the people affected and the doctors treating them. These quickly-developing cancers happen at the point when bone growth is at its fastest, and so show up in ways that are very different to cancers in adults. Knowing what causes these cancers is important, as it helps families spot the warning signs sooner, and lets doctors begin treatment quickly. 

Osteosarcoma happens when bones grow fast; it usually affects people aged ten to twenty. This primary bone cancer begins in bones, and isn’t a cancer which has spread to bones from somewhere else - which is what makes it different to metastatic disease. Inherited tendencies, along with what people are exposed to in their environment and how they develop, all contribute to the risk of getting the disease, though in most cases it happens without any clear external reason. 

How Genetic Mutations Drive Tumour Development 

Around 5-10% of osteosarcoma cases are due to inherited cancer syndromes, because of certain genetic faults being passed down through families. Li-Fraumeni syndrome - caused by changes to the TP53 gene - greatly increases risk, along with many other cancers during the lives of people who have it. People who have survived retinoblastoma and carry mutations in the RB1 gene have a much greater chance of getting osteosarcoma, especially if radiation treatment in the past damaged bone tissue around the area when they were children. 

Rothmund-Thomson syndrome, Werner syndrome, and Bloom syndrome are more inherited conditions which link instability in chromosomes with a greater chance of getting bone cancer. These unusual conditions disrupt the normal ways that DNA repairs itself, and so allow cancerous mutations to build up without being checked in fast-growing bone cells. Families who have several cancer diagnoses over generations should receive genetic advice to find inherited mutations which require more careful monitoring. 

Growth Spurts and Skeletal Development Create Vulnerability 

Teenage growth spurts create times of very intense cell division, when osteosarcoma most often appears. Bones get longer through activity at growth plates - where cartilage changes into new bone tissue through processes which require millions of cells to divide. Mistakes during this quick multiplication create chances for cancerous changes, which is why taller teenagers have a slightly higher risk than shorter ones. 

Long bones which are growing the most – the femur, tibia and humerus – more often develop osteosarcoma than smaller bones. The bottom of the femur, near the knee, and the top of the tibia, below it, are the most common places, and make up about half of all cases. The quickly-multiplying cells in these areas of high growth are more likely to suffer mutations which change normal osteoblasts into cancerous cells. 

Environmental Exposures and Radiation History 

Previous radiation therapy for other cancers greatly increases the chances of getting osteosarcoma, decades after the original treatment. Children who have radiation for retinoblastoma, leukaemia or other cancers of childhood have a greater risk during their lives in the bone areas which were previously radiated. This osteosarcoma caused by radiation usually appears 10-20 years after treatment, and so people who have had radiation therapy need to be monitored for a long time. 

High doses of radiation - more than 30 Gray - carry the greatest risk, though even moderate doses used in treatment raise the basic chance of getting cancer. 

Diagnostic imaging – like X-rays and CT scans – doesn’t give off enough radiation to cause osteosarcoma, despite what some people believe. Radiation from work or accidents is very rare as a cause in modern medicine. 

Advanced diagnostic techniques allow for accurate staging before treatment starts. Centres like Fortis Memorial Research Institute, Gurgaon combine modern imaging technology with knowledge from many different kinds of medical specialist for a complete assessment. This combined approach makes sure patients get correct diagnoses, and that treatment teams can make the best plans for therapy. 

Recognising Early Warning Signs and Symptoms 

Osteosarcoma symptoms develop slowly as growing cancers get bigger inside bones, at first causing occasional discomfort that families often think is just normal growing pains or sports injuries. Pain usually gets worse at night and when people are physically active, and stays around for longer than you would expect after ordinary sprains. This particular pattern – pain at night which doesn’t go away with rest – should make people get medical advice immediately, and not just wait and see. 

Swelling in a particular place over the affected bones appears as cancers break through the outer layer of the bone, creating lumps which get bigger and bigger over weeks or months. A smaller range of movement develops when cancers affect joints, making it harder to do normal things like running, climbing stairs or taking part in sports. Sometimes, a weakened bone breaks with ordinary force – a pathological fracture – and this can unexpectedly show an underlying cancer. 

Paget’s Disease and Other Bone Problems 

Existing bone illnesses make changes to the cells which can encourage cancer to develop in adults. Paget’s disease causes unusual bone rebuilding, with too much breakdown and growth weakening the skeleton, and also creating conditions for cells to multiply. About 1 in every 100 people with Paget’s disease gets secondary osteosarcoma – usually after the age of 40, once many years of unusual bone change have built up. 

Fibrous dysplasia and enchondromas are further harmless bone growths which can, on occasion, turn into osteosarcoma. These changes are uncommon but people with large problems in their skeleton should be watched regularly. Multiple hereditary exostoses – many harmless bone growths on the skeleton – has a small risk of turning cancerous and so people with this condition need to be checked at intervals throughout their lives. 

Treatment Methods Using Chemotherapy Plans 

Current osteosarcoma chemotherapy plans use strong mixes of several drugs, given both before and after the cancer is removed by surgery. Chemotherapy before surgery – neoadjuvant chemotherapy – reduces the size of tumours, and may allow a limb to be saved instead of being removed. Doxorubicin, cisplatin, and high-dose methotrexate are the main drugs, and consistently work against osteosarcoma cells. 

Chemotherapy after surgery – adjuvant chemotherapy – gets rid of any microscopic cancer, and so stops it spreading – particularly to the lungs, where osteosarcoma most often goes. Treatment usually lasts 6 to 12 months, and needs hospital stays for cycles of strong drug giving. How a tumour responds to chemotherapy before surgery – shown by how much of the tumour dies after it is removed – predicts how well a patient will do in the long term: over 90% tumour death means a very good outlook. 

Telling Osteosarcoma Apart From Other Bone Cancers 

Olfactory neuroblastoma, despite the name, is a completely different cancer from osteosarcoma: it comes from the nerves in the nose, not from bone. This rare tumour grows in the olfactory epithelium, causing blockage of the nose, nosebleeds, and smell problems, not bone pain. The confusion in names is because “neuroblastoma” describes several cancers coming from nerves, in different parts of the body, and through different illnesses. 

Ewing sarcoma is another primary bone cancer, affecting similar ages, but coming from different cells, having different genes, and responding differently to treatment. Osteosarcoma comes from bone-forming cells, but Ewing sarcoma comes from very early nerve tissue in bone marrow. Correct diagnosis by a pathologist tells these two apart, and so directs the right treatment plan. 

Modern scanning techniques – including PET-CT – show how active a tumour’s metabolism is, and so tell aggressive tumours from harmless bone growths; MRI shows how far the cancer has gone into soft tissue, and so helps plan surgery. Similarly, olfactory neuroblastoma needs thorough scanning to be staged, although the anatomy is very different – being in the nose and sinuses, not the skeleton. 

New Research on Immunotherapy and Targeted Treatments 

Normal osteosarcoma chemotherapy is still the standard treatment, even though survival rates have not much improved in recent years. Researchers are looking at immunotherapy – using the body’s own immune system to recognise and destroy cancer cells – and checkpoint inhibitors have shown some early promise in cancer that has come back. Targeting particular gene changes which drive individual tumours is another area being investigated, but osteosarcoma’s complex changes in chromosomes makes it difficult to develop targeted treatments. 

Mifamurtide, a drug to boost the immune system, and which is allowed in some countries, activates macrophages to attack tumour cells when given with normal chemotherapy. Clinical trials are looking at other new drugs, offering hope for better results than the 60-70% long-term survival rate for cancer which is found only in one place. Cancer which has spread, or has come back, needs new methods, and so research goes on at specialist centres around the world. 

Understanding How Complex Risk Factors Work Together 

The causes of osteosarcoma are not usually single, but several factors coming together to change normal bone cells into cancer. Genetic weaknesses make a basic susceptibility, which environmental effects or developmental factors then turn into active disease. The rarity of osteosarcoma – about 3 cases per million people a year – suggests that many protective mechanisms usually stop cancer developing, despite the usual growth spurts and occasional gene changes. 

Most teenagers who have fast bone growth do not get bone cancer, showing that protective cells in the body effectively repair damage to DNA in normal circumstances. When hereditary cancer illnesses, radiation, or existing bone illness damage these defences, osteosarcoma symptoms appear as genetic damage builds up, and overcomes the ability to repair it. This multi-factor model explains why it is hard to predict risk for individuals, but population patterns show clear factors which contribute, and so need more careful watching.